Aug 25, 20222 minANNOUNCEMENTSCOPERNICO Study Published in International Journal of Infectious Disease
Sep 30, 20214 minCANCER RESEARCHPembrolizumab may be the new standard of care for RCC with intermediate to high risk of recurrence
Sep 2, 20213 minANNOUNCEMENTSCOPERNICO Results at ERS: immunotherapy combo reduces hospitalization for COVID-19 pneumonia
Feb 18, 20213 minANNOUNCEMENTSPECATI: New clinical trial with pembrolizumab and lenvatinib for patients with advanced thymic tumor
